Papers

20 results
|
Article Tier 2

Ameliorative effects of mulberry fruit anthocyanin extract on gut microbiota and liver metabolites in high-fat and high-cholesterol diet-fed ApoE−/− mice

Researchers investigated mulberry anthocyanin extract in high-fat, high-cholesterol diet-fed mice and found it reduced LDL cholesterol and inflammatory markers while favorably shifting gut microbial composition and modulating liver metabolites including glutamine and ATP, suggesting a mechanism linking gut microbiota to atherosclerosis risk reduction.

2026 Frontiers in Nutrition
Article Tier 2

Black Lycium barbarum polysaccharide attenuates LPS-induced intestine damage via regulation gut microbiota

Researchers studied whether a polysaccharide from black Lycium barbarum could protect against intestinal damage caused by bacterial toxins in mice. They found that the supplement alleviated intestinal tissue damage and improved gut microbiota diversity by promoting beneficial bacteria. The study suggests that this plant-derived polysaccharide may help maintain intestinal health by modulating the gut microbial community.

2023 Frontiers in Microbiology 16 citations
Article Tier 2

Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by Ligilactobacillus salivarius Li01

Researchers found that the probiotic Ligilactobacillus salivarius Li01 alleviates constipation in mice by modulating the serotonin signaling pathway, improving intestinal barrier function, and altering gut microbiota composition.

2022 Nutrients 38 citations
Article Tier 2

Gut microbiota remodeling drived by dietary millet protein prevents the metabolic syndrome

Researchers found that millet bran protein extract prevented metabolic syndrome in high-fat diet mice by remodeling gut microbiota and reducing obesity, chronic inflammation, and insulin resistance. The protective effects were linked to specific gut microbial metabolites influenced by dietary millet protein.

2023 Food Science and Human Wellness 5 citations
Article Tier 2

Erchen Decoction Alleviates High-Fat Diet + AOM/DSS-Induced CRC by Ameliorating Cholesterol-Bile Acid Metabolism Disorder through Regulating FXR and the Gut Microbiota

Researchers found that Erchen Decoction, a traditional Chinese medicine formula, alleviates colorectal cancer progression in a high-fat diet mouse model by correcting cholesterol-bile acid metabolism disorders through modulation of FXR signaling and gut microbiota composition.

2023 Research Square (Research Square)
Article Tier 2

Characterizing the Gut Microbial Metabolic Profile of Mice with the Administration of Berry-Derived Cyanidin-3-Glucoside

This paper is not about microplastics — it characterizes how the berry-derived compound cyanidin-3-glucoside alters gut microbiome composition and metabolic profiles in mice.

2023 Metabolites 2 citations
Article Tier 2

The Potential Role and Effective Components of Sanyeqing as the Potential Therapeutic Candidates for IBD and CRC

This review examines the phytochemical constituents of Sanyeqing (a traditional medicinal plant) and their therapeutic potential for inflammatory bowel disease and colorectal cancer, identifying anti-inflammatory and anti-tumor mechanisms that could complement conventional treatments.

2025 OncoTargets and Therapy
Article Tier 2

Jianwei Xiaoshi oral liquid attenuates high-calorie diet-induced dyspepsia in immature rats via regulating the pancreatic secretion pathway and maintaining the homeostasis of intestinal microbiota

Researchers found that a traditional Chinese herbal medicine formula called Jianwei Xiaoshi oral liquid improved functional digestive problems in young rats fed a high-calorie diet by regulating eight key proteins involved in pancreatic digestion and restoring healthy gut bacteria balance. The findings suggest potential therapeutic benefits of this herbal remedy for diet-induced digestive disorders in children.

2025 Chinese Medicine 1 citations
Article Tier 2

The potential mechanism of huazhuojiedu decoction in the treatment of ulcerative colitis based on network pharmacology and experimental validation

Researchers used network pharmacology to identify 119 active components and 146 potential targets of the traditional Chinese medicine formula Huazhuojiedu decoction relevant to ulcerative colitis, then validated key predicted mechanisms in dextran sulfate sodium-induced rat colitis models, elucidating multi-target pathways underlying the formula's clinically observed therapeutic effects.

2022 Frontiers in Pharmacology 3 citations
Article Tier 2

Highlights

A study examined the therapeutic potential of snail mucus enriched with carob extract, finding in animal models that it could reduce markers of colitis and inflammation, suggesting a novel approach to managing inflammatory bowel conditions using a food-derived bioactive ingredient.

2025 Chemistry & Industry
Article Tier 2

An Ilex latifolia‐containing compound tea regulates glucose–lipid metabolism and modulates gut microbiota in high‐fat diet‐fed mice

This study investigated how a compound tea containing Kuding Tea, green tea, and Luohan fruit affects glucose and lipid metabolism in mice fed a high-fat diet. Researchers found that the tea blend helped regulate metabolic parameters and modulated gut microbiota composition, suggesting potential benefits for managing metabolic health.

2024 Food Frontiers 2 citations
Article Tier 2

Fermented Wheat Bran Polysaccharides Improved Intestinal Health of Zebrafish in Terms of Intestinal Motility and Barrier Function

Researchers found that fermented wheat bran polysaccharides improved intestinal health in zebrafish by enhancing intestinal motility and barrier function, suggesting their potential as functional food additives for gut health.

2023 Fermentation 7 citations
Article Tier 2

Modulation of Gut Microbial Metabolism by Cyanidin-3-O-Glucoside in Mitigating Polystyrene-Induced Colonic Inflammation: Insights from 16S rRNA Sequencing and Metabolomics

A natural plant compound called cyanidin-3-O-glucoside (C3G), found in red bayberry and other berries, reduced colon inflammation caused by polystyrene microplastic exposure in mice. C3G worked by reshaping the gut bacteria community and restoring healthy levels of anti-inflammatory signaling molecules. This suggests that certain dietary antioxidants may help protect the gut from damage caused by microplastic exposure.

2024 Journal of Agricultural and Food Chemistry 22 citations
Article Tier 2

Sodium Humate Alleviates Enterotoxigenic Escherichia coli-Induced Intestinal Dysfunction via Alteration of Intestinal Microbiota and Metabolites in Mice

Researchers found that sodium humate supplementation alleviated intestinal damage caused by enterotoxigenic Escherichia coli infection in mice by improving gut microbiota composition, modulating metabolites, and reducing intestinal inflammation and barrier dysfunction.

2022 Frontiers in Microbiology 27 citations
Article Tier 2

Combined Omics Analysis Further Unveils the Specific Role of Butyrate in Promoting Growth in Early-Weaning Animals

Researchers investigated whether dietary butyrate supplementation could improve intestinal health and growth in early-weaned rabbits using combined transcriptomic and metabolomic analysis. They found that butyrate strengthened the intestinal barrier, improved gut microbial balance by suppressing harmful bacteria, and enhanced metabolic pathways related to inflammation reduction and antioxidant capacity. The study suggests that butyrate supplementation may help alleviate the intestinal disruption commonly caused by early weaning in young animals.

2023 International Journal of Molecular Sciences 17 citations
Article Tier 2

Novel Characterization of Constipation Phenotypes in ICR Mice Orally Administrated with Polystyrene Microplastics

Researchers found that oral administration of 0.5 micrometer polystyrene microplastics to ICR mice for two weeks induced significant constipation-like phenotypes, including altered water consumption, reduced stool weight and water content, and changes in gastrointestinal transit markers. The study provides direct experimental evidence that microplastic ingestion can disrupt bowel function in mammals.

2021 International Journal of Molecular Sciences 33 citations
Clinical Trial Tier 1

Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

This Mendelian randomization study found genetic evidence supporting a causal relationship between specific gut microbiota compositions and gastrointestinal diseases. The findings suggest that microbiome-related interventions, including microbiome-dependent metabolites, could potentially be developed to treat or manage gastrointestinal conditions.

2024 Journal of Translational Medicine 36 citations
Article Tier 2

A probiotic for preventing microplastic toxicity: Clostridium dalinum mitigates microplastic-induced damage via microbiota-metabolism-barrier interactions

Using metagenomics and metabolomics, this study found that the probiotic bacterium Clostridium dalinum reduced microplastic-induced gut damage in mice by modulating gut microbiota composition, metabolic pathways, and intestinal barrier integrity.

2025 Current Research in Food Science
Article Tier 2

Supplementation of Miso to a Western-Type Diet Stimulates ILC3s and Decreases Inflammation in the Small Intestine

Miso supplementation in mice on a Western-type diet stimulated intestinal ILC3 immune cells and reduced small intestine inflammation, with the functional capacity of ILC3s to produce IL-22 proving more important than their absolute numbers for immune regulation.

2024 Nutrients 5 citations
Article Tier 2

Micro(nano)plastics in food system: potential health impacts on human intestinal system.

This review assessed how micro(nano)plastics in the human food system reach the intestine and accumulate in the gut, summarizing evidence that they can alter intestinal barrier function, trigger inflammation, and disrupt the gut microbiome, with implications for long-term digestive health.

2024 Critical reviews in food science and nutrition